Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-021539
Filing Date
2016-07-26
Accepted
2016-07-26 17:16:29
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20160630.htm 10-Q 748189
2 EX-31.1 mnov-ex311_6.htm EX-31.1 10994
3 EX-31.2 mnov-ex312_7.htm EX-31.2 10899
4 EX-32.1 mnov-ex321_9.htm EX-32.1 7872
5 EX-32.2 mnov-ex322_8.htm EX-32.2 7801
  Complete submission text file 0001564590-16-021539.txt   2638331

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20160630.xml EX-101.INS 381009
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20160630.xsd EX-101.SCH 26293
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20160630_cal.xml EX-101.CAL 24259
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20160630_def.xml EX-101.DEF 78906
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20160630_lab.xml EX-101.LAB 225401
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20160630_pre.xml EX-101.PRE 167600
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 161785048
SIC: 2834 Pharmaceutical Preparations